Literature DB >> 20194715

TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen.

Anna M Tan1, Hui-Chen Chen, Pierre Pochard, Stephanie C Eisenbarth, Christina A Herrick, H Kim Bottomly.   

Abstract

Allergic asthma is an inflammatory lung disease driven by Th2. We have shown that both Th1 and Th2 sensitization to inhaled OVA depend on the presence and concentration of LPS, where high concentrations (LPS(hi)) induce Th1 and low concentrations (LPS(lo)), Th2. Stromal cells (SCs), such as airway SCs, exacerbate established airway disease; however, little is known about their role early during sensitization. In this study, using bone marrow chimeric mice to restrict TLR4 signaling to either the SC compartment (SC(+)HPC(-)) or the hematopoietic cell (HPC) compartment (SC(-)HPC(+)), we report that HPC TLR4 is necessary and sufficient for Th1 sensitization to OVA-LPS(hi), whereas TLR4 in both compartments is required for Th2 sensitization to OVA-LPS(lo). Surprisingly, although SC(+)HPC(-) mice were unable to generate a Th1 response to OVA-LPS(hi), they instead mounted a robust Th2 response, indicating that in the presence of higher concentrations of LPS, SC TLR4 is sufficient for Th2 sensitization. We show that the SC TLR4 response to LPS leads to induction of Th2-inducing dendritic cells that upregulate Notch ligand Jagged-1 but not Delta-4. Furthermore, airway SCs upregulate thymic stromal lymphopoietin in response to exposure to both OVA-LPS(lo) and OVA-LPS(hi). These studies demonstrate that SC TLR4 signaling is critically involved in Th2 but not Th1 sensitization to inhaled Ag.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20194715     DOI: 10.4049/jimmunol.0900340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages.

Authors:  Tarcio Teodoro Braga; Matheus Correa-Costa; Yuri Felipe Souza Guise; Angela Castoldi; Cassiano Donizetti de Oliveira; Meire Ioshie Hyane; Marcos Antonio Cenedeze; Simone Aparecida Teixeira; Marcelo Nicolas Muscara; Katia Regina Perez; Iolanda Midea Cuccovia; Alvaro Pacheco-Silva; Giselle Martins Gonçalves; Niels Olsen Saraiva Camara
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

Review 2.  Allergen-specific pattern recognition receptor pathways.

Authors:  Marsha Wills-Karp
Journal:  Curr Opin Immunol       Date:  2010-11-17       Impact factor: 7.486

Review 3.  The airway epithelium in asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

4.  Assessment of recent developmental immunotoxicity studies with bisphenol A in the context of the 2015 EFSA t-TDI.

Authors:  Ellen V S Hessel; Janine Ezendam; Fleur A van Broekhuizen; Betty Hakkert; Jamie DeWitt; Berit Granum; Laurence Guzylack; B Paige Lawrence; Andre Penninks; Andrew A Rooney; Aldert H Piersma; Henk van Loveren
Journal:  Reprod Toxicol       Date:  2016-06-25       Impact factor: 3.143

5.  Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization.

Authors:  Matthew W Parsons; Li Li; Aaron M Wallace; Min Jung Lee; Howard R Katz; James M Fernandez; Shinobu Saijo; Yoichiro Iwakura; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

6.  The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.

Authors:  Karim H Shalaby; Saba Al Heialy; Kimitake Tsuchiya; Soroor Farahnak; Toby K McGovern; Paul-Andre Risse; Woong-Kyung Suh; Salman T Qureshi; James G Martin
Journal:  Immunology       Date:  2017-06-20       Impact factor: 7.397

7.  Vehicular exhaust particles promote allergic airway inflammation through an aryl hydrocarbon receptor-notch signaling cascade.

Authors:  Mingcan Xia; Loida Viera-Hutchins; Maria Garcia-Lloret; Magali Noval Rivas; Petra Wise; Sean A McGhee; Zena K Chatila; Nancy Daher; Constantinos Sioutas; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2015-03-29       Impact factor: 10.793

Review 8.  Notch and inflammatory T-cell response: new developments and challenges.

Authors:  Kazuhiro Mochizuki; Shan He; Yi Zhang
Journal:  Immunotherapy       Date:  2011-11       Impact factor: 4.196

9.  Prostaglandin E2 reduces Toll-like receptor 4 expression in alveolar macrophages by inhibition of translation.

Authors:  Angela Juliette Degraaf; Zbigniew Zasłona; Emilie Bourdonnay; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2014-08       Impact factor: 6.914

10.  Delta-like 4 differentially regulates murine CD4 T cell expansion via BMI1.

Authors:  Matthew A Schaller; Hannah Logue; Sumanta Mukherjee; Dennis M Lindell; Ana Lucia Coelho; Pamela Lincoln; William F Carson; Toshihiro Ito; Karen A Cavassani; Stephen W Chensue; Cory M Hogaboam; Nicholas W Lukacs; Steven L Kunkel
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.